Trials / Completed
CompletedNCT00343382
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
Pilocarpine for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Alliance for Clinical Trials in Oncology · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Pilocarpine may decrease vaginal dryness and improve quality of life in patients with breast cancer It is not yet known whether pilocarpine is more effective than a placebo in treating vaginal dryness in patients with breast cancer. PURPOSE: This randomized phase III trial is studying pilocarpine to see how well it works compared to a placebo in treating vaginal dryness in patients with breast cancer.
Detailed description
OUTLINE: This is a randomized, double-blind, placebo-controlled, multicenter study. Patients are stratified according to age (18 to 45 vs 46 to 55 vs 56 to 65 vs \> 65), concurrent tamoxifen therapy (yes vs no vs unknown \[e.g., on a blinded clinical study\]), concurrent aromatase inhibitor therapy (yes vs no vs unknown \[e.g., on a blinded clinical study\]), and perception of severity of vaginal symptoms at baseline (mild vs moderate vs severe). Patients are randomized to 1 of 4 treatment arms. The primary and secondary objectives of the study are described below. OBJECTIVES: Primary * Determine the effectiveness of pilocarpine hydrochloride for alleviation of vaginal dryness in patients with breast cancer. Secondary * Evaluate any toxicities arising from pilocarpine hydrochloride in these patients. * Evaluate quality of life of these patients treated with pilocarpine hydrochloride. Quality of life was assessed at baseline and then weekly for 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pilocarpine hydrochloride | Given orally |
| OTHER | placebo | Given orally |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2009-07-01
- Completion
- 2012-12-01
- First posted
- 2006-06-23
- Last updated
- 2016-08-12
- Results posted
- 2014-09-30
Locations
192 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00343382. Inclusion in this directory is not an endorsement.